Jump to main content
Jump to site search

Issue 20, 2001
Previous Article Next Article

Optimisation of the allylsilane approach to C-10 deoxo carba analogues of dihydroartemisinin: synthesis and in vitroantimalarial activity of new, metabolically stable C-10 analogues

Author affiliations

Abstract

An optimised protocol has been developed for the coupling of dihydroartemisinin benzoate with a range of aromatic allylsilanes to provide a number of new C-10 deoxo derivatives (11a–11g) in yields ranging from 70 to 94%. These compounds were up to ten times more potent than artemisinin in in vitro tests against the chloroquine resistant K1 strain of Plasmodium falciparum. Ferrous mediated degradation of these analogues produces as the main product, a dicarbonyl formate 12, which is not seen when the same reaction is carried out with artemisinin or artemether. This finding may indicate that analogues in this class have a subtly different “antimalarial” mechanism of action.

Graphical abstract: Optimisation of the allylsilane approach to C-10 deoxo carba analogues of dihydroartemisinin: synthesis and in vitro antimalarial activity of new, metabolically stable C-10 analogues

Back to tab navigation

Additions and corrections

Publication details

The article was received on 17 May 2001, accepted on 13 Aug 2001 and first published on 19 Sep 2001


Article type: Paper
DOI: 10.1039/B104340B
J. Chem. Soc., Perkin Trans. 1, 2001, 2682-2689

  •   Request permissions

    Optimisation of the allylsilane approach to C-10 deoxo carba analogues of dihydroartemisinin: synthesis and in vitro antimalarial activity of new, metabolically stable C-10 analogues

    P. M. O'Neill, M. Pugh, A. V. Stachulski, S. A. Ward, J. Davies and B. K. Park, J. Chem. Soc., Perkin Trans. 1, 2001, 2682
    DOI: 10.1039/B104340B

Search articles by author

Spotlight

Advertisements